Stay updated on Nivolumab in Type B3 Thymoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Type B3 Thymoma Clinical Trial page.

Latest updates to the Nivolumab in Type B3 Thymoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new Revision: v3.4.2 is added, and the previous government-funding maintenance notice and the Revision: v3.4.1 entry have been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA system notice about a lapse in government funding was added, and the page revision was updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedAdded Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; Removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated to v3.3.4; the previous tag v3.3.3 was removed. This is a metadata update and does not alter any study information displayed on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a site revision note 'Revision: v3.3.3' to the footer and removed the 'HHS Vulnerability Disclosure' link along with the older 'Revision: v3.3.2' reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedPublications section wording updated to clarify PubMed-sourced publications and add Revision: v3.3.2; the prior PubMed description was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Type B3 Thymoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Type B3 Thymoma Clinical Trial page.